Drug intelligence / Profile preview

autologous bone marrow-derived mesenchymal stem cells (University Hospitals Cleveland Medical Center)

Development stage
Unknown
Lead developer
University Hospitals Cleveland Medical Center
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intradiscal
01

Overview

This investigational cell therapy, developed by University Hospitals Cleveland Medical Center, utilizes autologous bone marrow-derived mesenchymal stem cells (BM-MSCs) for the treatment of symptomatic intervertebral disc degeneration. The procedure involves harvesting the patient's own bone marrow, expanding the MSCs in culture, and then re-injecting them percutaneously under image guidance directly into the nucleus pulposus of the affected disc. The therapy aims to facilitate disc repair and regeneration, potentially alleviating chronic low back pain in patients who have not responded to conservative treatments.

Other names
Autologous MSCs for Degenerated Disc DiseaseAutologous BM-MSCs

Beyond the preview

Go deeper on autologous bone marrow-derived mesenchymal stem cells (University Hospitals Cleveland Medical Center).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous bone marrow-derived mesenchymal stem cells (University Hospitals Cleveland Medical Center).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call